From the Journals

Spotlight on Technology & Technique: Double Teaming Dry Eye

In November 2023, Lumenis Vision announced OptiPLUS, a dual-frequency RF device that delivers heat across various tissue layers, increasing blood circulation.

Share

5 Key Takeaways

  • 1

    OptiPLUS complements OptiLIGHT for multi-layered dry eye treatment.

  • 2

    It addresses inflammation and improves meibomian gland functionality with 1-MHz and 4-MHz wavelengths.

  • 3

    Combining IPL with multifrequency RF significantly improves expressible meibomian glands, meibum clarity, and symptoms.

  • 4

    Typically, a patient needs four treatments with each device.

  • 5

    The treatment is comfortable, feeling like a massage.

Original Source(s)

Spotlight on Technology & Technique: Double Teaming Dry Eye

In November 2023, Lumenis Vision announced OptiPLUS, a dual-frequency RF device that delivers heat across various tissue layers, increasing blood circulation.

  • by LOUIS PILLA, CONTRIBUTING EDITOR

  • November 1, 2024

  • 6 min

Related Content

Why I Built a Beauty Brand as an Ophthalmologist

Bridging the divide between eye health and cosmetics represents the natural evolution of compassionate, patient-centered care

Asymptomatic Meibomian Gland Characteristics 

Silent gland failure: what do asymptomatic adults reveal about subclinical MGD?

  • January 14, 2026

  • 3 min
FDA Approves Amneal’s Cyclosporine Ophthalmic Emulsion 0.05% for Dry Eye

Cyclosporine ophthalmic emulsion 0.05% is the generic equivalent of Restasis, a registered trademark of Allergan, an AbbVie company.